31/07/2007 - New data show Russia’s clinical trials industry may have been impacted by the recent temporary biologics ban. Meanwhile the country is attempting to introduce tighter clinical trial regulations.The country’s Federal Agency for Health Care and Social Development (Roszdravnadzor) issued 114 permits to conduct clinical trials in Russia in the second quarter of this year, a 13 per cent decrease on the comparable period last year.
